Microba Life Sciences Ltd
ASX:MAP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.07
0.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Microba Life Sciences Ltd
Other
Microba Life Sciences Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Other
-AU$384.7k
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Other
-AU$52.6m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Other
-AU$160k
|
CAGR 3-Years
75%
|
CAGR 5-Years
37%
|
CAGR 10-Years
24%
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Other
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Other
-AU$73.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-25%
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Other?
Other
-384.7k
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Other amounts to -384.7k AUD.
What is Microba Life Sciences Ltd's Other growth rate?
Other CAGR 3Y
41%
Over the last year, the Other growth was 69%. The average annual Other growth rates for Microba Life Sciences Ltd have been 41% over the past three years .